🇺🇸 Amlodipine+Benazepril in United States

680 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 104 reports (15.29%)
  2. Drug Ineffective — 89 reports (13.09%)
  3. Nausea — 87 reports (12.79%)
  4. Diarrhoea — 83 reports (12.21%)
  5. Dizziness — 59 reports (8.68%)
  6. Headache — 57 reports (8.38%)
  7. Completed Suicide — 54 reports (7.94%)
  8. Dyspnoea — 54 reports (7.94%)
  9. Pain — 47 reports (6.91%)
  10. Arthralgia — 46 reports (6.76%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Amlodipine+Benazepril approved in United States?

Amlodipine+Benazepril does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Amlodipine+Benazepril in United States?

TSH Biopharm Corporation Limited is the originator. The local marketing authorisation holder may differ — check the official source linked above.